Genetic Signatures Limited (ASX:GSS)
Australia · Delayed Price · Currency is AUD 0.0870
+0.0060 (7.41%)
Sep 8, 2026, 1:35 PM AEST
Genetic Signatures Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 9.07 | 7.47 | 36.25 | 16.35 | 36.9 |
Short-Term Investments | 13.03 | 23.82 | - | - | - |
Cash & Short-Term Investments | 22.1 | 31.3 | 36.25 | 16.35 | 36.9 |
Cash Growth | -29.40% | -13.67% | 121.74% | -55.69% | 22.50% |
Accounts Receivable | 2.06 | 2.55 | 3.25 | 3.19 | 3.64 |
Other Receivables | 5.01 | 5.07 | 6.33 | 8.07 | 0.49 |
Receivables | 7.07 | 7.62 | 9.58 | 11.26 | 4.13 |
Inventory | 6.21 | 9.06 | 6.72 | 8.75 | 10.2 |
Total Current Assets | 35.37 | 47.98 | 52.55 | 36.37 | 51.23 |
Property, Plant & Equipment | 3.09 | 6.66 | 8.49 | 7.22 | 6.78 |
Other Intangible Assets | - | - | 6.25 | 5.49 | 1.65 |
Total Assets | 38.46 | 54.63 | 67.29 | 49.08 | 59.65 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 1.29 | 2.38 | 3.07 | 3.77 | 3.42 |
Accrued Expenses | 0.43 | 0.73 | 1.11 | 1.27 | 1.11 |
Current Portion of Leases | 0.31 | 0.44 | 0.39 | - | 0.03 |
Other Current Liabilities | 0.67 | 0.55 | 0.67 | 1.03 | 0.25 |
Total Current Liabilities | 2.7 | 4.1 | 5.23 | 6.07 | 4.81 |
Long-Term Leases | 0 | 0.35 | 0.83 | - | 0 |
Pension & Post-Retirement Benefits | 0.03 | 0.09 | 0.12 | 0.1 | 0.05 |
Total Liabilities | 2.73 | 4.54 | 6.18 | 6.16 | 4.85 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 127.65 | 127.65 | 119.43 | 84.44 | 84.43 |
Retained Earnings | -101.12 | -87.11 | -67.01 | -49.15 | -35.1 |
Comprehensive Income & Other | 9.2 | 9.56 | 8.68 | 7.62 | 5.47 |
Shareholders' Equity | 35.72 | 50.09 | 61.1 | 42.91 | 54.8 |
Total Liabilities & Equity | 38.46 | 54.63 | 67.29 | 49.08 | 59.65 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 0.31 | 0.79 | 1.22 | - | 0.03 |
Net Cash (Debt) | 21.79 | 30.5 | 35.03 | 16.35 | 36.86 |
Net Cash Growth | -28.58% | -12.92% | 114.27% | -55.65% | 24.03% |
Net Cash Per Share | 0.10 | 0.13 | 0.21 | 0.11 | 0.25 |
Filing Date Shares Outstanding | 227.14 | 227.14 | 215.27 | 143.41 | 143.39 |
Total Common Shares Outstanding | 227.14 | 227.14 | 215.27 | 143.41 | 143.39 |
Working Capital | 32.67 | 43.88 | 47.32 | 30.3 | 46.43 |
Book Value Per Share | 0.16 | 0.22 | 0.28 | 0.30 | 0.38 |
Tangible Book Value | 35.72 | 50.09 | 54.86 | 37.43 | 53.16 |
Tangible Book Value Per Share | 0.16 | 0.22 | 0.25 | 0.26 | 0.37 |
Machinery | 13.93 | 14.09 | 14.16 | 12.69 | 10.94 |